We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Top Sells

Rank Stock Value
1
SIAL
SIGMA - ALDRICH CORP
SIAL
+$48.6M
2
JPM icon
JPMorgan Chase
JPM
+$47.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$46.2M
4
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
+$31.6M
5
KIM icon
Kimco Realty
KIM
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOS icon
1676
A.O. Smith
AOS
$8.84B
– –
-8,268
Closed -$269K
APD icon
1677
Air Products & Chemicals
APD
$65.8B
– –
-16,447
Closed -$1.94M
ARCB icon
1678
ArcBest
ARCB
$3.33B
– –
-14,331
Closed -$369K
AROC icon
1679
Archrock
AROC
$6.12B
– –
-71,418
Closed -$1.29M
ASH icon
1680
CALL
Ashland
ASH
$3.14B
– –
-13,286
Closed -$654K
ASH icon
1681
PUT
Ashland
ASH
$3.14B
– –
-44,150
Closed -$2.17M
ASHR icon
1682
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
– –
-17,900
Closed -$579K
ASTE icon
1683
Astec Industries
ASTE
$1.28B
– –
-7,878
Closed -$264K
ATI icon
1684
ATI
ATI
$25.4B
– –
-27,311
Closed -$388K
AVGO icon
1685
Broadcom
AVGO
$1.82T
– –
-134,000
Closed -$1.68M
AXON
1686
Axon Enterprise
AXON
$43.5B
– –
-10,505
Closed -$231K
BABA icon
1687
Alibaba
BABA
$277B
– –
-5,577
Closed -$438K
BAH icon
1688
Booz Allen Hamilton
BAH
$8.73B
– –
-9,177
Closed -$241K
BAP icon
1689
Credicorp
BAP
$31.1B
– –
-7,936
Closed -$844K
BBY icon
1690
CALL
Best Buy
BBY
$19B
– –
-30,000
Closed -$1.11M
BBY icon
1691
PUT
Best Buy
BBY
$19B
– –
-30,000
Closed -$1.11M
BCC icon
1692
Boise Cascade
BCC
$2.85B
– –
-23,125
Closed -$583K
BCO icon
1693
Brink's
BCO
$4.83B
– –
-7,909
Closed -$213K
BCRX icon
1694
BioCryst Pharmaceuticals
BCRX
$2.43B
– –
-14,482
Closed -$165K
BG icon
1695
Bunge Global
BG
$22.5B
– –
-3,629
Closed -$266K
BH icon
1696
Biglari Holdings Class B
BH
$1.17B
– –
-1,343
Closed -$327K
BIO icon
1697
Bio-Rad Laboratories Class A
BIO
$8.79B
– –
-10,000
Closed -$1.34M
BLDR icon
1698
Builders FirstSource
BLDR
$7.95B
– –
-26,979
Closed -$342K
BLKB icon
1699
Blackbaud
BLKB
$1.66B
– –
-33,220
Closed -$1.86M
BLUE
1700
DELISTED
bluebird bio
BLUE
– –
-1,019
Closed -$1.13M
66 67
68
69 70

Similar funds

PWMG
Prestige Wealth Management Group Flemington, New Jersey $509M AUM 15.69% 1-Year Est. Return
NIEF
Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return
HIM
HughesLittle Investment Management Vancouver $511M AUM 24.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
OA
Oasis Advisors Forest City, Iowa $509M AUM
MC
Machina Capital Paris, France $508M AUM 9.91% 1-Year Est. Return
CTAF
Call To Action Foundation Salt Lake City, Utah $511M AUM 16.28% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $511M AUM 18.81% 1-Year Est. Return

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.